Shire spins out mRNA group to RaNA, which is hatching plans to tackle cystic fibrosis in the clinic
Over the last few years, the executive crew at Shire has on a few rare occasions spotlighted their work in mRNA, touting its potential for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.